Orthofix Medical Inc. operates primarily through two business segments: Global Spine and Global Limb Reconstruction. The Global Spine segment, which accounts for the vast majority of revenue, offers bone growth stimulation devices, spinal fixation implants, biologics, and the 7D FLASH navigation system for surgical procedures. The Global Limb Reconstruction segment provides external and internal fixation products for deformity correction, limb lengthening, and complex fracture management. Founded in 1980, the company significantly expanded its spine and biologics presence following its 2023 merger with SeaSpine. Orthofix distributes its medical technologies across more than 70 countries, serving healthcare providers and patients worldwide.
